2:
Effect of amphotericin B and micafungin combination on survival, histopathology, and fungal burden in experimental aspergillosis in the p47phox-/- mouse model of chronic granulomatous disease.
Dennis CG, Greco WR, Brun Y, Youn R, Slocum HK, Bernacki RJ, Lewis R, Wiederhold N, Holland SM, Petraitiene R, Walsh TJ, Segal BH.
Antimicrob Agents Chemother. 2006 Feb;50(2):422-7.
PMID: 16436692 [PubMed - indexed for MEDLINE]
Related Articles Free article in PMC
4:
Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B.
Ozsahin H, von Planta M, Müller I, Steinert HC, Nadal D, Lauener R, Tuchschmid P, Willi UV, Ozsahin M, Crompton NE, Seger RA.
Blood. 1998 Oct 15;92(8):2719-24.
PMID: 9763555 [PubMed - indexed for MEDLINE]
Related Articles
6:
Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation.
Bielorai B, Toren A, Wolach B, Mandel M, Golan H, Neumann Y, Kaplinisky C, Weintraub M, Keller N, Amariglio N, Paswell J, Rechavi G.
Bone Marrow Transplant. 2000 Nov;26(9):1025-8.
PMID: 11100285 [PubMed - indexed for MEDLINE]
Related Articles